63010-09-3 Usage
General Description
The chemical [1-(4-chlorophenyl)cyclobutyl]methanamine is a cyclobutylmethanamine derivative with a 4-chlorophenyl substituent. It is a compound that belongs to the class of organic compounds known as cyclobutyl carbinamines which are organic compounds containing a cyclobutane carbinamine moiety. [1-(4-chlorophenyl)cyclobutyl]methanamine is not readily available for purchase or commercial use, and it is not commonly reported in the scientific literature. Therefore, its specific properties and potential applications are not well-documented. However, as a cyclobutylmethanamine derivative, it may have potential uses in organic synthesis and pharmaceutical research.
Check Digit Verification of cas no
The CAS Registry Mumber 63010-09-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,3,0,1 and 0 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 63010-09:
(7*6)+(6*3)+(5*0)+(4*1)+(3*0)+(2*0)+(1*9)=73
73 % 10 = 3
So 63010-09-3 is a valid CAS Registry Number.
InChI:InChI=1/C11H14ClN/c12-10-4-2-9(3-5-10)11(8-13)6-1-7-11/h2-5H,1,6-8,13H2
63010-09-3Relevant articles and documents
P2X3 AND/OR P2X2/3 COMPOUNDS AND METHODS
-
Paragraph 0361-0364, (2018/04/17)
The present disclosure provides novel compounds and methods for preparing and using these compounds. In one embodiment, the compounds are of the structure of formula (I), wherein R1-R7 are defined herein. In a further embodiment, these compounds are useful in method for regulating one or both of the P2X3 or P2X2/3 receptors. In another embodiment, these compounds are useful for treating pain in patients by administering one or more of the compounds to a patient. In another embodiment, these compounds are useful for treating respiratory dysfunction in patients by administering one or more of the compounds to a patient.
Multidrug resistance modifying dithianes
-
, (2008/06/13)
Compounds of the formula STR1 wherein R is a residue of the formula STR2 and R1, R2, R3, R4, R5, R6, R7, X, Y and Z are as described, with the exception of rac-N-(3,4-dimethoxyphenethyl)-2-(3,4-dimethoxyphenyl)-β,N-dimethyl-m-dithiane-2-propanamine, as well as their acid addition salts, in particular for use in eliminating cytostatic resistance in tumor treatment and chloroquine resistance in malaria.
